RUNX2 and breast carcinoma: Meanwhile, TRIM21 inhibits the transcription of runx family transcription factor 2 (RUNX2) by regulating the degradation of set domain containing 7/9 (SET7/9), thereby inhibiting the malignant phenotype in breast cancer [44].